Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.75 USD | -1.12% | +5.53% | -12.66% |
07/05 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
07/05 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.66% | 1.9B | |
+28.15% | 48.16B | |
-0.63% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.64% | 25.59B | |
-22.94% | 18.96B | |
+8.04% | 12.92B | |
+29.74% | 12.03B | |
-2.22% | 11.77B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- JPMorgan Upgrades Beam Therapeutics to Overweight From Neutral, Raises Price Target to $40 From $38